298 related articles for article (PubMed ID: 8850099)
1. [Cytokine therapy and the endocrine system: is it necessary to monitor more than the thyroid gland?].
Schuppert F; Müller-Kunert E; Stöcker W; Bokemeyer C; Schmoll HJ; von zur Mühlen A; Rambusch EG
Med Klin (Munich); 1996 Feb; 91(2):59-65. PubMed ID: 8850099
[TBL] [Abstract][Full Text] [Related]
2. Low doses of subcutaneous interleukin-2 plus interferon-alpha do not induce thyroid function alterations in advanced renal cell carcinoma patients.
Sartore-Bianchi A; Soriani A; Mattioni R; Vaglio A; Buzio C; Porta C
Oncol Rep; 2004 Oct; 12(4):855-9. PubMed ID: 15375512
[TBL] [Abstract][Full Text] [Related]
3. [Occurrence and significance of autoantibodies in the course of interferon therapy of chronic hepatitis C].
Heller J; Musiolik J; Homrighausen A; Sauerbruch T; Spengler U
Dtsch Med Wochenschr; 1996 Sep; 121(39):1179-83. PubMed ID: 8925742
[TBL] [Abstract][Full Text] [Related]
4. Incidence of autoimmune thyroiditis in interferon-alpha treated and untreated patients with chronic hepatitis C virus infection.
Rocco A; Gargano S; Provenzano A; Nardone M; De Sanctis GM; Altavilla N; Chircu LV; Grimaldi F
Neuro Endocrinol Lett; 2001; 22(1):39-44. PubMed ID: 11335878
[TBL] [Abstract][Full Text] [Related]
5. Patients treated with interferon-alpha, interferon-beta, and interleukin-2 have a different thyroid autoantibody pattern than patients suffering from endogenous autoimmune thyroid disease.
Schuppert F; Rambusch E; Kirchner H; Atzpodien J; Kohn LD; von zur Mühlen A
Thyroid; 1997 Dec; 7(6):837-42. PubMed ID: 9459625
[TBL] [Abstract][Full Text] [Related]
6. [Thyroid dysfunctions in patients with viral hepatitis treated with interferon-alpha].
Földes I; Dávid K; Horváth G; Osztrogonácz H; Jankovics K; Tolvaj G
Orv Hetil; 2004 Jun; 145(23):1211-6. PubMed ID: 15264588
[TBL] [Abstract][Full Text] [Related]
7. [Interferon-alpha-induced disorders of thyroid function. A retrospective analysis of the literature and personal experiences].
Weissel M; Templ E; Gisslinger H
Acta Med Austriaca; 1995; 22(1-2):1-5. PubMed ID: 7645363
[TBL] [Abstract][Full Text] [Related]
8. [Antithyroid antibodies of varying specificity in the pathogenesis and diagnosis of autoimmune thyroid diseases].
Ivanova EV; Bogatyreva ZI; Isaeva MA; Suchkova EN; Baĭsugurov MA; Andreeva AV; Korotkova AA; Notkins A; Pal'tsev MA; Suchkov SV
Ter Arkh; 2009; 81(10):39-45. PubMed ID: 19947439
[TBL] [Abstract][Full Text] [Related]
9. Relation of anti-TPO autoantibody titre and T-lymphocyte cytokine production patterns in Hashimoto's thyroiditis.
Karanikas G; Schuetz M; Wahl K; Paul M; Kontur S; Pietschmann P; Kletter K; Dudczak R; Willheim M
Clin Endocrinol (Oxf); 2005 Aug; 63(2):191-6. PubMed ID: 16060913
[TBL] [Abstract][Full Text] [Related]
10. Autoantibodies in children with chronic hepatitis B infection and the influence of interferon alpha.
Kansu A; Kuloğlu Z; Demirçeken F; Girgin N
Turk J Gastroenterol; 2004 Dec; 15(4):213-8. PubMed ID: 16249973
[TBL] [Abstract][Full Text] [Related]
11. [Occurrence of various autoantibodies in autoimmune diseases].
Lacka K; Jarczewska K; Gembicki M
Pol Tyg Lek; 1989 Aug 7-14; 44(32-33):751-3, 770. PubMed ID: 2641801
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of HCV antibodies in autoimmune thyroid disease.
Testa A; Castaldi P; Fant V; Fiore GF; Grieco V; De Rosa A; Pazardjiklian MG; De Rosa G
Eur Rev Med Pharmacol Sci; 2006; 10(4):183-6. PubMed ID: 16910348
[TBL] [Abstract][Full Text] [Related]
13. Endocrine-mediated mechanisms of fatigue during treatment with interferon-alpha.
Jones TH; Wadler S; Hupart KH
Semin Oncol; 1998 Feb; 25(1 Suppl 1):54-63. PubMed ID: 9482541
[TBL] [Abstract][Full Text] [Related]
14. Clinical results of anti-inflammatory therapy in Graves' ophthalmopathy and association with thyroidal autoantibodies.
Eckstein AK; Plicht M; Lax H; Hirche H; Quadbeck B; Mann K; Steuhl KP; Esser J; Morgenthaler NG
Clin Endocrinol (Oxf); 2004 Nov; 61(5):612-8. PubMed ID: 15521965
[TBL] [Abstract][Full Text] [Related]
15. Polyspecificity of antimicrosomal thyroid antibodies in hepatitis C virus-related infection.
Peoc'h K; Dubel L; Chazouillères O; Ocwieja T; Duron F; Poupon R; Johanet C
Am J Gastroenterol; 2001 Oct; 96(10):2978-83. PubMed ID: 11693336
[TBL] [Abstract][Full Text] [Related]
16. The role of thyroid autoantibodies in the development of thyroid dysfunction in Taiwanese chronic hepatitis C patients with interferon-alpha and ribavirin combination therapy.
Huang JF; Chuang WL; Dai CY; Chen SC; Lin ZY; Lee LP; Lee PL; Wang LY; Hsieh MY; Chang WY; Yu ML
J Viral Hepat; 2006 Jun; 13(6):396-401. PubMed ID: 16842442
[TBL] [Abstract][Full Text] [Related]
17. Frequency of diabetes and thyroid autoantibodies in patients with autoimmune endocrine disease from Cameroon.
Hawa MI; Picardi A; Costanza F; D'Avola D; Beretta Anguissola G; Guglielmi C; Mottini G; Fezeu L; Mbanya JC; Leslie RD; Pozzilli P
Clin Immunol; 2006; 118(2-3):229-32. PubMed ID: 16298164
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer in association with thyroid disorders.
Michalaki V; Kondi-Pafiti A; Gennatas S; Antoniou A; Primetis H; Gennatas C
J BUON; 2009; 14(3):425-8. PubMed ID: 19810133
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of the auto-aggressive processes in patients with hypothyroid Hashimoto's thyroiditis following substitutive treatment with L-thyroxine.
Guclu F; Ozmen B; Kirmaz C; Kafesciler SO; Degirmenci PB; Taneli F; Hekimsoy Z
Eur Cytokine Netw; 2009 Mar; 20(1):27-32. PubMed ID: 19318318
[TBL] [Abstract][Full Text] [Related]
20. Autoimmune thyroid disease and autoimmune rheumatic disorders: a two-sided analysis.
Lazúrová I; Benhatchi K; Rovenský J; Kozáková D; Wagnerová H; Tajtáková M; Shoenfeld Y; Macejova Z
Ann N Y Acad Sci; 2009 Sep; 1173():211-6. PubMed ID: 19758153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
